Rivas-Meléndez R, Padilla-del CKN

Language: Spanish
References: 13
Page: 134-138
PDF size: 251.91 Kb.

ABSTRACT

Introduction: osteoporosis is characterized by low bone mass, deterioration of the microarchitecture of bone tissue, decreased strength and bone fragility, which increases the risk of fractures, with hip, spine, and wrist being the most affected sites. Objective: the study focuses on determining the prevalence of fragility fractures in patients with osteoporosis at the Civil Hospital of Guadalajara "Fray Antonio Alcalde". Material and methods: this was an observational study whose statistical analysis used Pearson correlation tests with R squared, Student's t-test, and χ² test to compare means, with a value of p ≤ 0.05 considered significant. The total population consisted of 800 patients who underwent axial bone densitometry of lumbar vertebrae and hip at the Osteoporosis Clinic of HCFAA in 2019 with a diagnosis of osteoporosis, of whom 63 patients were included in the non-probabilistic sample. Results: the study included 63 patients (59 women and four men) with an average age of 67.6 years and a mean T-score of -3.0 ± 23.8% of patients had suffered at least one fragility fracture and the wrist was the most prevalent site of the 19 documented fractures. A significant relationship was found between low bone density and the presence of at least one fragility fracture. Conclusions: medical treatment and education about the disease should be provided, even in the absence of symptoms, to prevent fragility fractures, as suffering one will reduce quality and life expectancy.

REFERENCES

1. Reza-Albarrán AA. Osteoporosis. Gac Med Mex. 2016;152(1):84-89.

2. Zanchetta J. The Latin America Regional Audit: Epidemiología, costos e impacto de la osteoporosis en 2012. Sao Paulo: International Osteoporosis Foundation; 2012.

3. Sanz-Granada A. Fracturas osteoporóticas (I). Offarm. 2004;23(2):104-143.

4. Canalé ST. Campbell cirugía ortopédica. Tratado de traumatología y ortopedia. 11a ed. España: Elsevier; 2009.

5. Delgado Martínez A. Cirugía ortopédica y traumatología. 3a ed. España: Panamericana; 2015.

6. Terán Dávila J, Teppa Garrán AD. Actualidad en el tratamiento de la osteoporosis posmenopáusica. Rev Obstet Ginecol Venez. 2003;63(3):135-148.

7. Hermoso de Mendoza MT. Clasificación de la osteoporosis. Factores de riesgo. Clínica y diagnóstico diferencial. An Sist Sanit Navar. 2003;26(3):29-52.

8. Munson JC, Bynum JPW, Bell JE, McDonough C, Wang Q, Tosteson T, et al. Impact of prescription drugs on second fragility fractures among US Medicare patients. Osteoporos Int. 2018;29(12):2771-2779.

9. Diagnóstico y tratamiento de osteoporosis en mujeres postmenopáusicas: Guía de Práctica Clínica. México: CENETEC; 2018.

10. Etxebarria-Foronda I, Caeiro-Rey JR, Larrainzar-Garijo R, Vaquero-Cervino E, Roca-Ruiz L, Mesa-Ramos M, et al. Guía SECOT-GEIOS en osteoporosis y fractura por fragilidad. Actualización. Rev Esp Cir Ortop Traumatol. 2015;59(6):373-393.

11. Clark P, Cons-Medina F. The Latin American Regional Audit Epidemiología, costos e impacto de la osteoporosis en 2012. México: International Osteoporosis Foundation; 2012. pp. 45-52.

12. Carlos F, Clark P, Galindo-Suárez RM, Chico-Barba LG. Health care costs of osteopenia, osteoporosis, and fragility fractures in Mexico. Arch Osteoporos. 2013;8:125.

13. Clark P, Tamayo JA, Cisneros F, Rivera FC, Valdés M. Epidemiology of osteoporosis in Mexico. Present and future directions. Rev Invest Clin. 2013;65(2):183-191.